Phase 3 Chronic Myeloid Leukemia Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Study of Olverembatinib (HQP1351) in Patients With CP-CML
Chronic Myeloid LeukemiaCMLCML, Chronic Phase
Ascentage Pharma Group Inc.285 enrolled1 locationNCT06423911
Recruiting
Phase 3
A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Chronic Myeloid Leukemia, Chronic PhaseCML, Chronic PhaseCML, Refractory+1 more
Il-Yang Pharm. Co., Ltd.173 enrolled18 locationsNCT03459534
Recruiting
Phase 3
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Chronic Myeloid LeukemiaTyrosine Kinase Inhibitors
Poitiers University Hospital140 enrolled20 locationsNCT05753384
Completed
Phase 2Phase 3
Open Label Study of Subcutaneous Omacetaxine in Patients With Advanced Chronic Myeloid Leukemia.
Chronic Myeloid Leukemia
ChemGenex Pharmaceuticals Inc.100 enrolled9 locationsACTRN12609000377235
Completed
Phase 2Phase 3
Omacetaxine in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Chronic Myeloid Leukemia
ChemGenex Pharmaceuticals Inc.100 enrolled28 locationsACTRN12609000373279